Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience.

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease.

Diagnosing heart failure in children with congenital heart disease and respiratory syncytial virus bronchiolitis.

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.

Respiratory syncytial virus and reactive airway disease.

Retrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases.

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.

Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.

Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease.

Quality of life in adults living with congenital heart disease: beyond morbidity and mortality.

Low fasting plasma glucose level predicts morbidity and mortality in symptomatic adults with congenital heart disease.

Recent advances in congenital heart disease genomics.

Respiratory syncytial virus prophylaxis reduces chronic respiratory morbidity in prematurely born infants.

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.

An R.S.V.P. to R.S.V. (respiratory syncytial virus): declining mortality rates.

Respiratory syncytial virus infections.

Respiratory syncytial virus in nurseries.

Animal models of respiratory syncytial virus infection and disease.

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.

Palivizumab and respiratory syncytial virus disease: selling sickness for future?

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.

Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK.

Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

New options in the treatment of respiratory syncytial virus disease.

Respiratory syncytial virus as a cause of acute respiratory infections in adults. An emerging disease?

Suggest Documents

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease.

Diagnosing heart failure in children with congenital heart disease and respiratory syncytial virus bronchiolitis.

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.

Respiratory syncytial virus and reactive airway disease.

Retrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases.

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.

Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.

Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease.

Quality of life in adults living with congenital heart disease: beyond morbidity and mortality.

Low fasting plasma glucose level predicts morbidity and mortality in symptomatic adults with congenital heart disease.

Recent advances in congenital heart disease genomics.

Respiratory syncytial virus prophylaxis reduces chronic respiratory morbidity in prematurely born infants.

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.

An R.S.V.P. to R.S.V. (respiratory syncytial virus): declining mortality rates.

Respiratory syncytial virus infections.

Respiratory syncytial virus in nurseries.

Animal models of respiratory syncytial virus infection and disease.

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.

Palivizumab and respiratory syncytial virus disease: selling sickness for future?

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.

Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK.

Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

New options in the treatment of respiratory syncytial virus disease.

Respiratory syncytial virus as a cause of acute respiratory infections in adults. An emerging disease?

Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience.

Recommend Documents

Follow Us